Atlas Trials

Combination Chemotherapy With Pazopanib in Children and Adolescents With Relapsed/Refractory Solid Tumors

Clinical trial NCT03628131 · UNKNOWN

Trial details

NCT number
NCT03628131
Sponsor
Samsung Medical Center
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Relapsed Pediatric Solid TumorRefractory Pediatric Solid Tumor
Start date
2018-10-01
Primary completion
2023-07-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.